Stock comparison
JEENA SIKHO LIFECARE
JSLL.NS$69.25BHealthcare Market cap, Sector
LeMaitre Vascular
LMAT$2.15BHealthcare Market cap, Sector
Overall winner
JEENA SIKHO LIFECARE
JSLL.NS 70 LMAT
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
Fit scores by strategy
JSLL.NS7wins
0winsLMAT
84B
B73
87A
A85
92A
B77
66C
C63
75B
D52
91A
C64
95A
C65
Side-by-side metrics
| Metric | JSLL.NS | LMAT |
|---|---|---|
| Market cap | Winner: $69.25B | $2.15B |
| P/E (TTM) | Winner: 33.3x | 37.1x |
| EV/EBIT | Winner: 24.1x | 36.6x |
| ROIC (TTM) | Winner: 39.15% | 9.43% |
| Gross margin | Winner: 88.58% | 72.39% |
| Net margin | Winner: 27.68% | 24.35% |
| Revenue CAGR 5y | Winner: 57.81% | 12.75% |
| EPS CAGR 5y | Winner: 86.67% | 19.04% |
| Debt / Equity | Winner: 0.3x | 0.5x |
| Dividend yield | - | 0.84% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
JSLL.NS leads on
- Market cap$69.25Bvs $2.15B+97%
- EPS CAGR 5y86.67%vs 19.04%+78%
- Revenue CAGR 5y57.81%vs 12.75%+78%
- ROIC (TTM)39.15%vs 9.43%+76%
LMAT leads on
No clear edges - the other side wins or ties on every measured metric.
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.